Despina B.
- Country
- Bulgaria
- Department
- Department of Cardiology
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 124 of 642 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating patients with atherosclerotic cardiovascular disease (ASCVD), focusing on preventive approaches for major cardiovascular events.
- Cardiovascular death prevention
- Heart attack management
- Stroke prevention strategies
Research involves innovative lipid-lowering therapeutic approaches for patients with elevated LDL cholesterol levels.
Cardiac Rhythm Disorders
The investigator focuses on managing patients with atrial fibrillation, particularly those at elevated risk for stroke and systemic embolism.
- Stroke prevention in atrial fibrillation
- Systemic embolism prevention
- Bleeding risk management
Clinical interest extends to evaluating novel anticoagulation strategies for cardiac rhythm disorders.
Therapeutic Innovation
The investigator explores advanced therapeutic approaches in cardiovascular medicine, with particular attention to comparing treatment efficacy and safety profiles.
- Comparative treatment effectiveness
- Risk-benefit assessment
- Cardiovascular outcomes research
Expertise includes evaluation of novel therapeutic agents for cardiovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.